Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis CA Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

被引：0

作者：

Gaetano Scotto

Vincenzina Fazio

Chiara Fornabaio

Alessandra Tartaglia

Rocco Di Tullio

Annalisa Saracino

Gioacchino Angarano

机构：

[1] University of Foggia,Clinic of Infectious Diseases

[2] Hospital of Foggia,Clinical Chemistry Laboratory

来源：

Drugs | 2008年 / 68卷

关键词：

Viral Load; Sustained Virological Response; Early Virological Response; Viral Kinetic; Standard Interferon;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objectives: The purpose of this randomized open-label study was to assess the efficacy of treatment with pegylated interferon-α-2a versus pegylated interferon-α-2b, both plus ribavirin, in inducing early and sustained virological response (EVR and SVR) in chronic hepatitis C non-responders.

引用

页码：791 / 801

页数：10

共 50 条

[21] Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
Gong-Ying Chen
Meng-Fei Zhu
Da-Liang Zheng
Yan-Ting Bao
Jie Wang
Xiang Zhou
Guo-Qiang Lou
World Journal of Gastroenterology, 2014, (25) : 8195 - 8200
[22] Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
Chen, Gong-Ying
Zhu, Meng-Fei
Zheng, Da-Liang
Bao, Yan-Ting
Wang, Jie
Zhou, Xiang
Lou, Guo-Qiang
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (25) : 8195 - 8200
[23] Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B
Helvaci, M
Kizilgunesler, A
Kasirga, E
Ozbal, E
Kuzu, M
Sozen, G
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 785 - 791
[24] Interferon-α-2b/pegylated interferon and ribavirin treatment in renal disease with renal insufficiency and chronic hepatitis C infection
Bruchfeld, A
Lindahl, K
Schvarcz, R
Ståhle, L
ANTIVIRAL THERAPY, 2002, 7 (04) : L127 - L127
[25] Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy:: a randomized trial
Salmeron, J.
Diago, M.
Andrade, R.
Perez, R.
Sola, R.
Romero, M.
de la Mata, M.
Granados, R.
Ruiz-Extremera, A.
Munoz de Rueda, P.
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (02) : 89 - 95
[26] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
Sinha, S
Gulur, P
Patel, V
Hage-Nassar, G
Tenner, S
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
[27] The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin
Pawlowski, Tomasz
Radkowski, Marek
Perlejewski, Karol
Laskus, Tomasz
Malyszczak, Krzysztof
PSYCHOSOMATIC MEDICINE, 2024, 86 (02): : 124 - 128
[28] Psychiatric Symptoms Induced by Antiviral Therapy in Chronic Hepatitis CComparison between Interferon-α-2a and Interferon-α-2b
Sergio Neri
Davide Pulvirenti
Gaetano Bertino
Clinical Drug Investigation, 2006, 26 : 655 - 662
[29] The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients
Dogan, Umit B.
Golge, Necmettin
Akin, Mustafa S.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (11) : 1312 - 1316
[30] Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
Bhushan, Shashi B. L.
Wanve, Sunil
Koradia, Parshottam
Bhomia, Vinay
Soni, Pravin
Chakraborty, Sisir
Khobragade, Akash
Joshi, Shashank
Mendiratta, Sanjeev Kumar
Kansagra, Kevin Kumar
Parihar, Anurag
Sharma, Sunil
Patel, Jatin
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 : 281 - 287

← 1 2 3 4 5 →